Cargando…
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
SUMMARY: Gaps in pharmacological treatment for osteoporosis can reduce effectiveness. Among older adults, we found about half of new users of oral bisphosphonate and denosumab persisted with their treatment at 2 years, with few switching to alternative therapy. Persistence is suboptimal and warrants...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053179/ https://www.ncbi.nlm.nih.gov/pubmed/33864529 http://dx.doi.org/10.1007/s11657-021-00932-7 |